Please assess the completion status of the following clinical trial:

Trial Title: AL-15469A for the Treatment of Bacterial Conjunctivitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* signs and symptoms of bacterial conjunctivitis~* Other protocol-defined inclusion criteria may apply~Exclusion Criteria:~* under 1 mo. age~* Other protocol-defined exclusion criteria may apply

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Moxifloxacin (Type: EXPERIMENTAL): None
- VIGAMOX (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).